Lung Cancer Screening (LCS)
Expanding Lung Cancer Screening Accessibility
Our Solutions
Increasing accessibility of lung cancer screening for the public, providing high-quality imaging at low dose, removing workflow inefficiencies, supporting the interpretation and communication of findings, and streamlining follow-up procedures.
Canon’s innovative imaging technologies address key concerns in lung cancer screening improving the patient experience and ensuring high-quality imaging, while minimizing the burden of the lung cancer on patients worldwide.
Improving Accessibility
Mobile CT imaging that enables you to perform scans anywhere and everywhere, expanding accessibility by bringing the screening experience closer to your patients.
Driving Operational Efficiency
Enhanced and automated workflow with AI-assisted INSTINX optimizes efficiency, ensuring consistent, quick and seamless CT scans.
Improving Diagnostic Confidence
Offering high-quality CT imaging with low noise and low doses with the combination of the SilverBeam filter and AiCE AI technologies.
Risk Stratification and Diagnosis
Vitrea Advanced Visualization enables automatic detectsion of lung nodules, for a comprehensive lung analysis while supporting fast and efficient diagnosis.
Improving Accessibility
Easy Access from Anywhere
One of the main challenges of lung cancer screening is reaching the people who may need it the most. Mobile imaging solutions allow you to provide healthcare and education where people live and work and offer screening close to their homes. By removing barriers to access, mobile imaging services may play a significant role in improving lung cancer screening rates and contribute to more equitable healthcare.
“Developing a mobile program allowed delivery of healthcare to rural parts of our state with the ultimate goal of mitigating some of the cancer outcome disparities of our state and region.”
Prof. Hannah Hazard-Jenkins, MD, FACS
Associate Professor of Surgery at the department of Surgery WVU School of Medicine
Director of the WVU Cancer Institute
Morgantown, West Virginia, USA
The clinical results, performance and views described here are the experience of the health care providers. Results may vary due to clinical setting, patient presentation and other factors. Many factors could cause the actual results and performance of Canon Medical’s product to be materially different from any of the aforementioned.
Enhancing Efficiency through Autonomous CT
INSTINX*, AI-Assisted Workflow Automation.
- Intuitive operation and intelligent automated workflows
- Simple and accurate scan planning
- Consistency between operators regardless of their experience
* Depending on system configuration.
1 Based on a study performed at Hakujyuji Hospital, Japan with 40 cases, 10 technologists comparing manual scan planning on Aquilion ONE with automatic scan planning on Serve for body examinations.
2 Based on an ALD evaluation of 240 3D Landmark scans (40 Head, 200 Body) 3D landmark scan data. Cases in which the relevant anatomic landmark(s) were not present (9) were excluded. 97% accuracy is based on results within +/- 1 cm of target start, end, and FOV position, confirmed by two experienced CT Technologists.
3 SURESubtraction Iodine Mapping and Bone Removal.
Ultra-low Dose Lung Cancer Screening
Assisting in Early Detection.
Ultra-low dose CT Lung Cancer Screening enabled by the SilverBeam filter in combination with AiCE DLR. The beam shaping energy filter leverages the photon-attenuating properties of silver to selectively remove low-energy photons from a polychromatic X-ray beam, leaving an optimized energy spectrum.
Sharp, Clear and Distinct Images at Low Doses
Advanced intelligent Clear-IQ Engine (AiCE).
Deep Learning Reconstruction (AiCE delivers our best low-contrast resolution ever1, with improved low-contrast detectability, noise and spatial resolution relative to hybrid iterative reconstruction.
11.5mm @0.3%, Aquilion ONE / GENESIS Edition
Filtered Back Projection
AiCE DLR
